- Smiths Group (“Smiths”) significantly ramping up production of its paraPAC plus™ ventilators, manufactured in its Smiths Medical facility in Luton, UK
- Smiths is at the centre of a UK Consortium working to deliver the UK Government target of 30,000 ventilators by making available the Smiths paraPAC plus™ device
- Smiths in dialogue with contract manufacturers to further add production capacity in the US and other countries to meet global demand
Smiths, the global technology company, (LSE: SMIN.L) announces that its Smiths Medical division is ramping up production of its paraPAC plus™ ventilator at its Luton site to meet increased demand from the UK and across Europe. Smiths Medical is working with its supply chain to increase weekly production over the next 2 weeks. Smiths is in dialogue with contract manufacturers in the US to increase its production levels of ventilators, to support the fight against the global shortage.
The impact of Covid-19 has created a worldwide shortage for ventilators, and Smiths is helping the UK Government deliver its ambitious plan of 5,000 additional ventilators within two weeks, with the intention to scale availability to 30,000 over the coming months. In addition to increasing its own production, Smiths will play a central role in the Industrial Consortium being formed by the UK Government. Smiths will provide IP and technical advice, and make available its paraPAC plus™ ventilator to the Consortium, in order to create additional UK sites and supply chains to deliver the objective.
In addition to providing ventilator units, Smiths is also increasing the production of specialist ventilator hoses through its Flex-Tek division in South Carolina, US for a number of ventilator manufacturers across the world.
Andrew Reynolds Smith, CEO of Smiths, said:
“During this time of national and global crisis it is our duty to assist in the efforts being made to tackle this devastating pandemic and I have been inspired by the hard work undertaken by our employees to achieve this aim. We are doing everything possible to substantially increase production of our ventilators at our Luton site and worldwide. Alongside this we are at the centre of the UK consortium working to set up further sites to materially increase the numbers available to the NHS and to other countries impacted by this crisis.”
About paraPAC plus™
Designed and manufactured in the UK, the Smiths Medical paraPAC plus™ ventilator provides the versatility to deliver mechanical ventilation, demand and free flow oxygen therapy all from one compact, lightweight unit. It’s been designed to be rugged, simple to use and doesn’t rely on an external electric supply – and so well suited to the needs of healthcare systems around the world.
Deborah Scott, FTI Consulting
+44 (0)797 953 7449
Alex Le May, FTI Consulting
+44 (0)7702 443 312
Smiths Detection to transform security screening at Munich Airport with 60 3D cabin bag scannersSmiths Detection to transform security screening at Munich Airport with 60 3D cabin bag scanners25 October 2023Smiths Detection, today announces that it will supply Munich Airport with 60 HI-SCAN 6040 CTiX carry-on baggage scanners.Read the full story >
UK Ministry of Defence awards Smiths Detection contractUK MoD awards Smiths Detection contract to develop and supply next generation chemical detection capability06 October 2023Smiths Detection awarded an £88 million contract to develop, manufacture, supply and support next generation Chemical Sense Equipment for the UK Ministry of Defence (MoD).Read the full story >
US Department of Defense Acquires Aerosol and Vapor Chemical Agent DetectorsUS Department of Defense Acquires Smiths Detection’s Next Generation Aerosol and Vapor Chemical Agent Detectors26 September 2023U.S. Department of Defense (DOD) has selected Smiths Detection to supply 122 portable Aerosol and Vapor Chemical Agent Detectors (AVCAD)Read the full story >